60 DEGREES PHARMACEUTICALS, INC. 8-K

What Happened 60 Degrees Pharmaceuticals, Inc. announced a 1-for-4 reverse stock split of its common stock. Stockholders approved the split on October 8, 2025 following the board's recommendation. The company filed a Certificate of Amendment with the Delaware Secretary of State on January 14, 2026, which became effective at 12:01 a.m. Eastern Time on January 20, 2026. At the Effective Time, every four issued and outstanding shares were automatically combined into one share; no fractional shares were issued — fractional amounts were rounded up to one whole share. The company issued a press release about the split on January 15, 2026.

Key Details

• Stockholder approval date: October 8, 2025 (board had recommended the amendment).
• Final reverse split ratio: 1-for-4 (each 4 shares → 1 share).
• Certificate of Amendment filed: January 14, 2026; effective January 20, 2026 at 12:01 a.m. ET.
• Fractional shares: not issued; fractional amounts rounded up to the next whole share.
• Related filings: Certificate of Amendment filed as Exhibit 3.1 and a January 15, 2026 press release filed as Exhibit 99.1 to the 8-K.

Why It Matters This filing legally changes the company’s share structure by consolidating every four outstanding shares into one share. For shareholders, the action reduces the number of shares held on a per-share basis (consolidated holdings) while proportionate ownership in the company remains the same. The 8-K does not state any changes to authorized shares or provide a rationale for the split. Investors should check brokerage accounts for updated share balances and adjusted per‑share pricing following the Effective Time.